InMed Pharmaceuticals (INM) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

InMed Pharmaceuticals Struggles With Losses Amid Revenue Decline
TipRanksFeb 14 23:04 ET
InMed Pharmaceuticals Board Reshuffle After Director Resignation
TipRanksFeb 14 15:17 ET
InMed Pharmaceuticals Second Quarter 2025 Earnings: US$3.65 Loss per Share (Vs US$3.71 Loss in 2Q 2024)
Yahoo FinanceFeb 14 06:27 ET
InMed Pharmaceuticals | 8-K: InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
SECFeb 13 09:39 ET · Announcements
InMed Pharmaceuticals GAAP EPS of -$3.64, Revenue of $1.11M
Seeking AlphaFeb 13 02:33 ET
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update
newsfileFeb 12 18:54 ET

Comments

Jaguar8

Feb 3 09:00

NEWS

$InMed Pharmaceuticals (INM.US)$
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
InMed Pharmaceuticals (NASDAQ: INM) has announced the selection of an intravitreal (IVT) formulation for INM-089as a drug candidate for treating dry age-related macular degeneration (AMD). The company has achieved successful delivery of the formulation at doses up to 10 times the projected therapeutic level, demonstrating a favorable pharmacokinetic profil...

ApexTradeZ

Jan 25 10:58

In the NEWS past 216 hrs - WL 🔥🚀

$Palantir (PLTR.US)$
$Foremost Lithium Resource & Technology (FMST.US)$ TOP WL Mon $Banzai International (BNZI.US)$ Act-on-Software Acquisition $NANO Nuclear Energy (NNE.US)$ Top Nuclear Sector $SoundHound AI (SOUN.US)$ Top 2025 AI dont get left wishing you bought low $N2OFF (NITO.US)$ more news coming over 2.00 soon $ImmunityBio (IBRX.US)$ Top Bio “Anktiva” will be a LEADER get on board SOON $ChargePoint (CHPT.US)$ I am hearing “buyout” rumors $Greenwave Technology Solutions (GWAV.US)$ Virginia ...

2

Jaguar8

Jan 22 06:32

NEWS

$InMed Pharmaceuticals (INM.US)$
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
InMed Pharmaceuticals (NASDAQ: INM)has been granted its first international Patent Cooperation Treaty (PCT) patent in Mexico for novel cannabinoid analog compounds. The patent, titled 'Cannabinoid analogs and methods for their preparation', has a 20-year term and covers therapeutic applications for pain, glaucoma, inflammatory disease, anxiety, and neurological conditionsincluding Parkinson...

1